nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antineoplastics/corticosteroids
|
|
|
2002 |
910 |
1 |
p. 6 |
artikel |
2 |
Azathioprine, mercaptopurine: risk of lymphoma in patients with IBD
|
|
|
2002 |
910 |
1 |
p. 4 |
artikel |
3 |
Bodyweight and risk of OC failure
|
|
|
2002 |
910 |
1 |
p. 4 |
artikel |
4 |
Brimonidine
|
|
|
2002 |
910 |
1 |
p. 6 |
artikel |
5 |
Carbamazepine
|
|
|
2002 |
910 |
1 |
p. 6 |
artikel |
6 |
Clindamycin
|
|
|
2002 |
910 |
1 |
p. 6 |
artikel |
7 |
Collagen
|
|
|
2002 |
910 |
1 |
p. 6-7 |
artikel |
8 |
Corticosteroids
|
|
|
2002 |
910 |
1 |
p. 7 |
artikel |
9 |
Dexamethasone
|
|
|
2002 |
910 |
1 |
p. 7 |
artikel |
10 |
Docetaxel/paclitaxel
|
|
|
2002 |
910 |
1 |
p. 7 |
artikel |
11 |
Fluorouracil/gemcitabine
|
|
|
2002 |
910 |
1 |
p. 8 |
artikel |
12 |
Fluticasone use associated with adrenal crisis
|
|
|
2002 |
910 |
1 |
p. 4 |
artikel |
13 |
Gastroduodenal safety of alendronic acid
|
|
|
2002 |
910 |
1 |
p. 3 |
artikel |
14 |
Gynaecomastia in men receiving antiretroviral therapy
|
|
|
2002 |
910 |
1 |
p. 3 |
artikel |
15 |
Interferon-α
|
|
|
2002 |
910 |
1 |
p. 8 |
artikel |
16 |
Irinotecan labelling updated in the US
|
|
|
2002 |
910 |
1 |
p. 2 |
artikel |
17 |
Lidocaine interaction
|
|
|
2002 |
910 |
1 |
p. 8 |
artikel |
18 |
Lithium interaction
|
|
|
2002 |
910 |
1 |
p. 8 |
artikel |
19 |
Methotrexate: increased incidence of Hodgkin's disease
|
|
|
2002 |
910 |
1 |
p. 3 |
artikel |
20 |
Metoclopramide/midazolam/pethidine/propofol
|
|
|
2002 |
910 |
1 |
p. 8-9 |
artikel |
21 |
Nicotine
|
|
|
2002 |
910 |
1 |
p. 9 |
artikel |
22 |
No increased risk of diabetes mellitus with clozapine
|
|
|
2002 |
910 |
1 |
p. 4 |
artikel |
23 |
No increased risk of fracture with low-dose inhaled corticosteroids
|
|
|
2002 |
910 |
1 |
p. 4 |
artikel |
24 |
Olanzapine
|
|
|
2002 |
910 |
1 |
p. 9 |
artikel |
25 |
Oxaliplatin
|
|
|
2002 |
910 |
1 |
p. 9 |
artikel |
26 |
Perhexiline interaction
|
|
|
2002 |
910 |
1 |
p. 9-10 |
artikel |
27 |
Piroxicam
|
|
|
2002 |
910 |
1 |
p. 10 |
artikel |
28 |
Propofol interaction
|
|
|
2002 |
910 |
1 |
p. 10 |
artikel |
29 |
Pyrimethamine-dapsone
|
|
|
2002 |
910 |
1 |
p. 10 |
artikel |
30 |
Safety update on COX-2 inhibitors
|
|
|
2002 |
910 |
1 |
p. 2 |
artikel |
31 |
Sodium phosphate
|
|
|
2002 |
910 |
1 |
p. 10 |
artikel |
32 |
Sulfaguanidine
|
|
|
2002 |
910 |
1 |
p. 10-11 |
artikel |
33 |
Thioridazine: risk of sudden death
|
|
|
2002 |
910 |
1 |
p. 3 |
artikel |
34 |
Ticlopidine
|
|
|
2002 |
910 |
1 |
p. 11 |
artikel |
35 |
Valaciclovir
|
|
|
2002 |
910 |
1 |
p. 11 |
artikel |
36 |
Valaciclovir
|
|
|
2002 |
910 |
1 |
p. 11 |
artikel |
37 |
Vancomycin
|
|
|
2002 |
910 |
1 |
p. 11 |
artikel |
38 |
Vancomycin
|
|
|
2002 |
910 |
1 |
p. 11 |
artikel |
39 |
Warfarin interaction
|
|
|
2002 |
910 |
1 |
p. 11-12 |
artikel |